Mini Review
Published on 17 Nov 2022
Paroxysmal dyspnoea in asthma: Wheeze, ILO or dysfunctional breathing?
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.1054791
- 2,893 views
- 4 citations
- Frontiers in Allergy
- Asthma
- Articles
Type at least 3 characters
83 articles
Articles
Perspective
Published on 14 Nov 2022
Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.1007593
- 4,428 views
- 3 citations
Review
Published on 21 Oct 2022
Asthma in elite athletes – do they have Type 2 or non-Type 2 disease? A new insight on the endotypes among elite athletes
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.973004
- 6,072 views
- 3 citations
Original Research
Published on 30 Sep 2022
Exercise-induced bronchoconstriction in university field hockey athletes: Prevalence, sex differences, and associations with dyspnea symptoms
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.994947
- 1,783 views
- 1 citation
Review
Published on 20 Sep 2022
Role of airway epithelial cell miRNAs in asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.962693
- 2,838 views
- 5 citations
Review
Published on 15 Sep 2022
Airway remodeling: The Drosophila model permits a purely epithelial perspective
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.876673
- 4,514 views
- 8 citations
Review
Published on 12 Sep 2022
Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.993937
- 2,284 views
- 2 citations
Review
Published on 11 Aug 2022
What is the added value of FeNO as T2 biomarker?
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.957106
- 6,074 views
- 9 citations
Original Research
Published on 31 May 2022
Daily Inhaled Corticosteroids Treatment Abolishes Airway Hyperresponsiveness to Mannitol in Defence and Police Recruits
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.864890
- 2,212 views
- 2 citations
Opinion
Published on 30 May 2022
Inflammatory Remission in T2 Severe Asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.923083
- 3,337 views
- 6 citations
Brief Research Report
Published on 18 May 2022
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.881218
- 5,445 views
- 13 citations
Review
Published on 29 Apr 2022
Sex Differences in Airway Remodeling and Inflammation: Clinical and Biological Factors
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.875295
- 4,412 views
- 22 citations
Original Research
Published on 27 Apr 2022
Epigenetic Differences in Long Non-coding RNA Expression in Finnish and Russian Karelia Teenagers With Contrasting Risk of Allergy and Asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.878862
- 2,573 views
- 4 citations
Correction
Published on 01 Apr 2022
Corrigendum: Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.892908
- 1,313 views
Review
Published on 25 Mar 2022
Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.852067
- 3,457 views
- 5 citations
Review
Published on 02 Feb 2022
Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.806391
- 7,867 views
- 23 citations